Activated AR, on the other hand, inhibited the growth of breast cancers driven by the ER through displacement of the ER and critical transcriptional co-activators from chromatin, which resulted in transcriptional downregulation (Hickey et al., 2021). This evidence concerns the gene AR and breast carcinoma.